Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ALTICE USA, INC. (OPTU)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 3
  • 1 comments

Optimum Reports First Quarter 2026 Results

Market reaction Comment Full text

EVERGY, INC. (EVRG)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 3
  • 1 comments

Evergy Announces First Quarter 2026 Results, Announces New Large Customer, Declares Quarterly Dividend and Reaffirms 2026 Guidance

Market reaction Comment Full text

MYERS INDUSTRIES INC (MYE)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 4
  • 1 comments

Myers Industries Announces 2026 First Quarter Results

Market reaction Comment Full text

STELLA INTERNATIONAL HOLDINGS LTD. (LILA)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 3
  • 1 comments

Liberty Latin America Reports Q1 2026 Results

Market reaction Comment Full text

CUSHMAN & WAKEFIELD LTD. (CWK)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 3
  • 1 comments

Cushman & Wakefield Reports Financial Results for the First Quarter 2026

Market reaction Comment Full text

BAUSCH + LOMB CORPORATION COMMON SHARES (BLCO)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 2
  • 1 comments

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

Market reaction Comment Full text

ECARX HOLDINGS INC. (ECX)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 5
  • 1 comments

ECARX Holdings to Report First Quarter 2026 Financial Results on May 19, 2026

Market reaction Comment Full text

CREATIVE MEDIA&COMMUNITY TRUST CORPORATION DUAL LISTED (U)

  • Business News
  • May 07, 2026, 11:00 UTC
  • 5
  • 1 comments

Unity Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

VIATRIS INC (VTRS)

  • Business News
  • May 07, 2026, 10:59 UTC
  • 5
  • 1 comments

Viatris Reports First-Quarter 2026 Financial Results

Market reaction Comment Full text

ACLARIS THERAPEUTICS, INC. (ACRS)

  • Business News
  • May 07, 2026, 10:59 UTC
  • 5
  • 1 comments

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Market reaction Comment Full text
  • Previous
  • 695
  • 696
  • 697
  • 698
  • 699
  • Next

Search

News categories

  • Technical Exchange News(12564)
  • Event(6229)
  • SEC News(289862)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(163907)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin